AssetID: 55395713
Headline: UNCAPTIONED: Finger-Prick Blood Test Trial Aims to Transform Alzheimer's Diagnosis
Caption: Finger-Prick Blood Test Trial Aims to Transform Alzheimer’s Diagnosis. An international clinical trial is testing whether a simple finger-prick blood test could help identify Alzheimer’s disease earlier and more easily. The study involves 1,000 volunteers aged over 60 across the UK, United States and Canada, analysing blood-based biomarkers linked to Alzheimer’s risk. Researchers are measuring levels of three proteins associated with the disease, including amyloid and tau, which can build up years before symptoms appear. Participants will also undergo current gold-standard tests, such as PET brain scans or lumbar punctures, to compare accuracy with the finger-prick method. These traditional tests are costly, invasive and rarely offered, raising hopes that a blood test could speed up diagnosis and widen access. GP Dr Michael Sandberg joined the trial after his mother’s experience with Alzheimer’s and described receiving a negative result as a “huge relief.”Experts say earlier and more accurate diagnosis is increasingly important as new treatments move closer to clinical use. Scientists stress that results from all participants must be analysed before confirming how reliable the test is at spotting Alzheimer’s risk. If successful, the test could one day be done at home, with samples mailed to labs, potentially opening the door to widespread dementia screening. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,Alzheimer’s disease,finger-prick blood test,Bio-Hermes-002 study,LifeArc,Global Alzheimer’s Platform Foundation,UK Dementia Research Institute,biomarkers,amyloid,tau proteins,PET scan comparison,lumbar puncture,early diagnosis,Michael Sandberg,dementia trial,international study,medical research,dementia diagnosis,blood testing,neurological disease,early detection,clinical trials,ageing population,healthcare innovation,non-invasive testing,biomarker research,public health,home testing,future treatments
PersonInImage: